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CORRECTION Open Access
Correction to: Update on the EFFECTS
study of fluoxetine for stroke recovery: a
randomised controlled trial in Sweden
Erik Lundström1,2*, Eva Isaksson2, Per Näsman3, Per Wester4,5, Björn Mårtensson6, Bo Norrving7, Håkan Wallén8,
Jörgen Borg4, Martin Dennis9, Gillian Mead9, Graeme J. Hankey10, Maree L. Hackett11,12,
Katharina S. Sunnerhagen13,14,15,16 and For the EFFECTS Trial Collaboration
Correction to: Trials (2020) 21:233
https://doi.org/10.1186/s13063-020-4124-7
Following publication of the original article [1], we were
notified that one of the corresponding author’s affiliations
was omitted. Affiliation no. 2 is now added to for Prof.
Erik Lundström.
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